Neil Doherty

Music, books, bikes, science, nature, friends and family. Oxford Nanopore employee who wants to drive beneficial change for all.

[Oxford Nanopore @nanopore]

Slow turnaround times can hamper efforts to control disease outbreaks.

Discover in our brochure how #nanopore sequencing empowers real-time data analysis, offering immediate insights to quickly guide public health actions.

Learn more: https://t.co/2I3in8vB9G #WYMM

[Libby Snell @Libby_Snell_]

Curious about sequencing #RNA directly including mod bases? Register to join me for this webinar (11 July) explaining how #directRNA seq works plus recent updates & how they might work for your research needs! I'll be available for Q&A afterwards too. @nanopore #mRNA Details⬇️

[Tip @Thidathipw]

Moving forward to clinical service 🤩

[🦠BortzVirologyGroup🇺🇸 @BortzGroup]

🦠 #Tuberculosis is on the rise! The future of #TB diagnostics is @nanopore amplicon sequencing. From 2 months culture and phenotypic drug susceptibility testing —> to 8 hours by #Ampore_TB #MDR #AMR #nanoporeconf #freezeTB (Dr S Buckwalter MayoClinic)

[Oxford Nanopore @nanopore]

Today we kick off London Calling 2024 with the data analysis workshops and virtual masterclasses. Join thousands online and learn how to supercharge your genomics research with nanopore technology.

Register now: https://t.co/Fi1PnqtziJ
#nanoporeconf #WYMM

[Daniel Fordham @fordham_dan]

Would you like to use Adative sampling but dont know where to start? Or, do you have THE set of coordinates you think that everyone should use? If either of these are yes, please feel free to browse the open apdative science catalogue. @nanopore
https://t.co/g1cFG9idPZ

[Aaron Pomerantz, PhD @AaronPomerantz]

Now that’s what I call a packed house! Thank you #ESCMID community and our fantastic speakers for an exciting symposium on @nanopore sequencing applied to long-read 16S, tuberculosis drug resistance, nanopore-only bacterial genome wgMLST, and the future of metagenomics

[Jasmine Sanghera @jsang__]

So excited to announce our partnership with @bugseq! #InfectiousDisease #ECCMID 🦠 @neildoc1980 @AaronPomerantz @nanopore

[Matthew Parker @bioinfomatt]

Natalia and I will be at #ECCMID2024 on the @nanopore booth - we'll be doing a data for breakfast on the #EPI2ME platform and the demos throughout the conference of AmPORE-TB, isolate sequencing (NO-MISS) and metagenomics/barcoding. Be sure to stop by and say hello!

[Oxford Nanopore @nanopore]

Introducing NO-MISS.
An end-to-end method for rapid, comprehensive isolate sequencing.

Flexible sample batching & cost efficiency make it ideal for detecting outbreaks, understanding microbial evolution, food safety, & clinical research.

Learn more: https://t.co/WyelI22p8z

[Matthew Parker @bioinfomatt]

Sample to answer. 🧫 ➡️ 📋

@nanopore #EPI2ME easy to use local analysis with wf-bacterial-genomes:

⭐️Assembly
⭐️Annotation
⭐️MLST
⭐️AMR
⭐️Bug specific analysis

MLST derived identity allows bespoke downstream modules like Salmonella serotyping with SeqSero2.

#WYMM

[Matthew Parker @bioinfomatt]

Stop by Grande Suite 2029 in Tower II to meet our P2 solo and P2 integrated devices. We’re also demoing EPI2ME analysis #AGBT #AGBT24

[Neil Doherty @neildoc1980]

https://t.co/YS0wIkAvCr

[BugSeq @bugseq]

Wow! 2023 has been incredible for BugSeq and our customers. We're thrilled to highlight some of our favorite uses of BugSeq over the past year with a new blog post: https://t.co/g9ydfdrbXK

[Matthew Parker @bioinfomatt]

Uladzimir Antonenka presenting his work on @nanopore targeted sequencing of TB achieving 90% sensitivity across the board with including the new BPAL regime.

[Anca Vasiliu @_AncaVasiliu_]

"Death by tuberculosis is caused by human built systems"

Such a strong speech by @johngreen
👏👏👏

[Oxford Nanopore @nanopore]

Straight from his talk on the showcase stage, @ManopPit shared how #nanopore sequencing has the potential to address the gaps in current clinical testing — from resolving missing CNVs to identifying complex structural variants. #nanoporeconf

[Ed Kuijper @EdKuijper2]

There is definite a place for Metagenomics in diagnostics of infectious diseases now , especially for Nanopore sequencing, according to David Eyre at #NSCMID2023

[Neil Doherty @neildoc1980]

We are going to take #Nanopore sequencing into the clinical laboratory. Come and find out what we’re working on at #NSCMID2023. Rumour has it, the Nordic labs are leading the way.

[Jakob Ørtvig @rtvig_j]

Looking to take your infectious disease research to the next level with rapid sequencing?
Come talk to Neil Doherty and myself if you are at #NSCMID2023 in lovely Örebro
@nanopore

[Matthew Parker @bioinfomatt]

Just look at this 🐳 of a release. Lots of updates from the @nanopore EPI2ME team; Enhancements to the app, loads of workflow tweaks, and a BRAND NEW (ish) workflow: wf-16s is an experiment where we've tuned wf-metagenomics for 16S/18S/ITS data! https://t.co/5YRWMg1yH2